Opus Genetics's total assets for Q1 2026 were $66.79M, an increase of 32.93% from the previous quarter. IRD total liabilities were $112.62M for the fiscal quarter, a 222.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.